rovalpituzumab tesirine
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for rovalpituzumab tesirine, covering 2018-07-11 to 2021-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE) [Phase 3]